Assessing the Cost|Effectiveness of Next|Generation Sequencing as ...

Assessing the Cost-Effectiveness of Next-Generation Sequencing as ...

We conducted a systematic review of existing evidence of the costs of NGS as a biomarker testing strategy in oncology and developed policy suggestions.

Assessing the Cost-Effectiveness of Next-Generation Sequencing as ...

Studies somewhat support the cost-effectiveness of NGS—evaluating NGS testing together with targeted therapies produced mixed evidence; however, NGS testing was ...

Cost-Effectiveness of Next-Generation Sequencing Versus Single ...

In the long term, using NGS would provide 1,188 additional quality-adjusted life-years (QALYs) in the target population compared with SgT. On the other hand, ...

Assessing the Cost-Effectiveness of Next-Generation Sequencing as ...

Assessing the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Approach in Oncology and Policy Implications: A Literature Review.

Assessing the Costs and Cost-Effectiveness of Genomic Sequencing

Sequencing costs have fallen fast since then, and the $1000 genome will soon be a reality [2,3,4,5]. Widespread use of whole genome or whole exome sequencing ( ...

Cost-effectiveness of next-generation sequencing for advanced ...

The total medical cost for the NGS group was $8,375 higher than that for the SGT group. The difference in drug costs accounted for most of the ...

Cost-effectiveness of next-generation sequencing for advanced EGFR

Objectives: This study aimed to evaluate the cost-effectiveness of next-generation sequencing (NGS) versus sequential single-gene testing ...

Cost-Effectiveness of Next-Generation Sequencing Versus Single ...

In the long term, using NGS would provide 1,188 additional quality-adjusted life-years (QALYs) in the target population compared with SgT. On ...

Next-generation sequencing in oncology: challenges in economic ...

Next-generation sequencing (NGS) identifies genetic variants to inform personalized treatment plans. Insufficient evidence of cost-effectiveness impedes the ...

EE65 Evaluating the Cost-Effectiveness of Next-Generation ...

The existing literature supports the cost-effectiveness of NGS as a biomarker testing strategy in oncology under the right circumstances. Furthermore, as the ...

Full article: Cost-effectiveness analysis of molecular diagnosis by ...

To assess the cost-effectiveness of using next-generation sequencing (NGS) compared to sequential single-testing (SST) for molecular diagnostic and treatment.

Assessing the cost-effectiveness of next-generation sequencing as a ...

Assessing the cost-effectiveness of next-generation sequencing as a biomarker testing approach in oncology and policy implications: A literature review.

Cost-effectiveness analysis comparing companion diagnostic tests ...

This work was performed in order to evaluate the cost-effectiveness of a unique exam using NGS (next generation sequencing) versus other routinely used tests.

Application of next‐generation sequencing to improve cancer ...

For the cost-effectiveness review, we only included the articles with economic evaluations of NGS in cancer care. We report the rate of ...

Next Generation Sequencing: A Review of the Cost Effectiveness ...

12 Guidelines were assessed using the Appraisal of Guidelines for Research and. Evaluation (AGREE) tool.13 A numeric score was not calculated, instead the ...

Diagnostic Value and Cost-Effectiveness of Next-Generation ...

The results of biomarker testing are subsequently used to select appropriate systemic therapy in these patients. Next-generation sequencing (NGS) ...

The cost-effectiveness of returning incidental findings from next ...

Assuming next-generation sequencing costs $500, the incremental cost-effectiveness ratio for primary screening of healthy individuals was $133,400 ...

Award 12/47/01

Next generation sequencing is a new approach which allows the simultaneous ... effectiveness will be assessed by comparing the costs of the different diagnostic ...

Assessing the Cost-Effectiveness of Next-Generation Sequencing as ...

Assessing the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Approach in Oncology and Policy Implications: A Literature ...

Economic evaluation of next‐generation sequencing techniques in ...

Evaluation by means of NGS panel strategy, including Lynch syndrome genes and other genes related to high-penetrance CRCP syndromes, resulted in ...